ELLSWORTH, Kan. (KSNW) – A woman from Ellsworth is navigating life with a rare neuromuscular disease. Tina Bruning learned of her diagnosis of Generalized Myasthenia Gravis, or gMG, in May 2021.

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

Post-treatment, all patients exhibited satisfactory improvements. The Myasthenia Gravis Foundation of America Quantitative Myasthenia Gravis (MGFA-QMG) scores, 15-item Myasthenia Gravis Quality of ...

How does the FcRn blockade mechanism of nipocalimab compare with current standard treatments for myasthenia gravis? So traditionally in myasthenia gravis, like the majority of immune-mediated ...

This review supports the potential of Sugammadex as an effective and safe reversal agent for neuromuscular blockades in MG patients Challenges in anesthesia reversal for patients with myasthenia ...